Affinity Asset Advisors, LLC Horizon Therapeutics Public LTD CO Transaction History

Affinity Asset Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $2.68 Million - $2.84 Million	-25,000 Reduced 55.56%	20,000 $2.18 Million
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $2.81 Million - $5.12 Million	45,000 New	45,000 $5.12 Million
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $3.57 Million - $5.24 Million	45,000 Added 150.0%	75,000 $5.98 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $2.59 Million - $3.29 Million	30,000 New	30,000 $3.16 Million
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $1.48 Million - $1.8 Million	-15,000 Closed	0 $0

Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $919,100 - $1.1 Million	-10,000 Reduced 40.0%	15,000 $1.64 Million
Q2 2021 Aug 13, 2021	SELL	$86.24 - $95.92 $862,400 - $959,200	-10,000 Reduced 28.57%	25,000 $2.34 Million
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $718,300 - $954,800	-10,000 Reduced 22.22%	35,000 $3.22 Million
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $3.02 Million - $3.8 Million	45,000 New	45,000 $3.29 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Asset Advisors, LLC with notifications on news.